Evidence map›Paper›PMID 34131228›Full record

ArticleScientific reports2021

Glucocorticoid resistance conferring mutation in the C-terminus of GR alters the receptor conformational dynamics.

Anna Kaziales, Florian Rührnößl, Klaus Richter

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Anna KazialesDepartment of Chemistry, Center for Integrated Protein Science Munich, Technische Universität München, Lichtenbergstr. 4, 85748, Garching, Germany. anna.kaziales@tum.de.
Florian RührnößlDepartment of Chemistry, Center for Integrated Protein Science Munich, Technische Universität München, Lichtenbergstr. 4, 85748, Garching, Germany.
Klaus RichterDepartment of Chemistry, Center for Integrated Protein Science Munich, Technische Universität München, Lichtenbergstr. 4, 85748, Garching, Germany. klaus.richter@richterlab.de.
Technical University of Munich · DECenter for Integrated Protein Science Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glucocorticoid receptor is a key regulator of essential physiological processes, which under the control of the Hsp90 chaperone machinery, binds to steroid hormones and steroid-like molecules and in a rather complicated and elusive response, regulates a set of glucocorticoid responsive genes. We here examine a human glucocorticoid receptor variant, harboring a point mutation in the last C-terminal residues, L773P, that was associated to Primary Generalized Glucocorticoid Resistance, a condition originating from decreased affinity to hormone, impairing one or multiple aspects of GR action. Using in vitro and in silico methods, we assign the conformational consequences of this mutation to particular GR elements and report on the altered receptor properties regarding its binding to dexamethasone, a NCOA-2 coactivator-derived peptide, DNA, and importantly, its interaction with the chaperone machinery of Hsp90.

Indexed as

AnimalsDexamethasoneDNAGlucocorticoidsHSP90 Heat-Shock ProteinsHumansMetabolism, Inborn ErrorsMolecular ChaperonesMolecular ConformationNuclear Receptor Coactivator 2PeptidesPoint MutationProtein BindingReceptors, GlucocorticoidDexamethasoneDNAGlucocorticoidsHSP90 Heat-Shock ProteinsMolecular ChaperonesNCOA2 protein, humanNuclear Receptor Coactivator 2PeptidesReceptors, Glucocorticoid

Identifiers

PMID34131228
PMCPMC8206104
OpenAlexW3170772438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.